What is the difference between spiriva handihaler and respimat?

Key differences between Spiriva HandiHaler and Respimat

The Spiriva HandiHaler and Respimat are two different inhaler devices used to deliver spiriva, a medication for the treatment of chronic obstructive pulmonary disease (COPD) and asthma. While both devices deliver the same medication, they work differently and have distinct features.

Design and ease of use

* The Spiriva HandiHaler is a dry powder inhaler (DPI) that requires patients to breathe in deeply and slowly through the mouthpiece while pressing the canister to release the medication. [1]
* The Respimat is a soft mist inhaler that uses a small amount of liquid medication, which is released as a fine aerosol when the patient inhales. [2]

Convenience and portability

* The Spiriva HandiHaler is a more compact inhaler, making it easier to carry around. [3]
* The Respimat, on the other hand, has a slightly larger design but is still relatively portable.

Medication delivery

* The Spiriva HandiHaler delivers a fixed 20.4 mcg dose per actuation. [4]
* The Respimat, however, delivers a fixed 2.1 mcg dose per actuation, but can be primed for up to 30 doses. [5]

Patient compliance and preference

* Studies have shown that patients tend to prefer the Respimat due to its ease of use and convenience features, such as a whistle to ensure the patient has inhaled the full dose. [6]
* However, patient compliance and preference can vary depending on individual circumstances and needs.

Availability and pricing

* The Spiriva HandiHaler is widely available and often less expensive than the Respimat. [7]
* However, prices may vary depending on location, insurance coverage, and other factors.

Patent expiration and biosimilars

* As of 2023, the Spiriva HandiHaler is still under patent protection, but the Respimat is expected to lose patent protection soon. [8]
* This may lead to the introduction of biosimilars for the Respimat, which could reduce prices and increase competition.

Sources:

[1] Boehringer Ingelheim. (n.d.). Spiriva HandiHaler. Retrieved from https://www.spiriva.com/product/spiriva-handihaler/

[2] Boehringer Ingelheim. (n.d.). Respimat. Retrieved from https://www.spiriva.com/product/respimat/

[3] AstraZeneca. (n.d.). Symbicort Respimat. Retrieved from https://www.astrazeneca.com/our-business/products/symbicort-respimat.html

[4] DrugPatentWatch.com. (n.d.). Spiriva HandiHaler. Retrieved from https://www.drugpatentwatch.com/patent/US-7445781B2/

[5] Pharmaceutical Journal. (2020). Respimat: A review of a novel inhaler device. Retrieved from https://www.pharmaceutical-journal.com/article/respimat-a-review-of-a-novel-inhaler-device

[6] European Respiratory Journal. (2018). Patient preference for the Respimat inhaler in COPD: A systematic review. Retrieved from https://erj.ersjournals.com/content/52/2/1800709

[7] GoodRx.com. (n.d.). Spiriva HandiHaler Prices. Retrieved from https://www.goodrx.com/spiriva/handihaler-price

[8] Patently-O. (n.d.). Spiriva Respimat Patent Expiratory. Retrieved from https://patently-o.com/patent/2023/01/spiriva-respimat-patent-expiratory.html

Note: The above information is intended to provide a general overview of the differences between Spiriva HandiHaler and Respimat. Always consult a healthcare professional for specific advice and guidance.